Week In Review: WuXi's SynTheAll Subsidiary Raises $80 Million
July 11, 2015 at 14:33 PM EDT
WuXi PharmaTech, a China-US CRO/CMO, announced its SynTheAll Pharma subsidiary, a small-molecule manufacturing company will raise $80 million through a private placement of 6% of its shares.
